133 related articles for article (PubMed ID: 8132249)
1. Effect of lead exposure on plasma phenylbutazone levels in rats.
Basu N; Kulsreshtha T
Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
[TBL] [Abstract][Full Text] [Related]
3. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
Scherkl R; Hashem A; Frey HH
Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
[TBL] [Abstract][Full Text] [Related]
4. [The concentration changes of different phenylbutazone formulations in horse plasma].
Keller H; Hashem A
Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
[TBL] [Abstract][Full Text] [Related]
5. Lead intoxication among demolition workers: the effect of lead on the hepatic cytochrome P-450 system in humans.
Fischbein A; Alvares AP; Anderson KE; Sassa S; Kappas A
J Toxicol Environ Health; 1977 Oct; 3(3):431-7. PubMed ID: 411946
[TBL] [Abstract][Full Text] [Related]
6. Serum vasoactive agents in lead-treated rats.
Skoczyńska A; Stojek E; Górecka H; Wojakowska A
Int J Occup Med Environ Health; 2003; 16(2):169-77. PubMed ID: 12921385
[TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
8. Chronic oral administration of rhamnogalacturonan-II dimer, a pectic polysaccharide, failed to accelerate body lead detoxification after chronic lead exposure in rats.
Tahiri M; Tressol JC; Doco T; Rayssiguier Y; Coudray C
Br J Nutr; 2002 Jan; 87(1):47-54. PubMed ID: 11895313
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
12. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
13. [Antibiotic levels in blood serum and mandibular bone in rats with and without phenylbutazone administration].
Teseromati C; Papadopoulos J; Storaiti E; Tralil H
Hell Stomatol Chron; 1988; 32(1):29-31. PubMed ID: 3153680
[TBL] [Abstract][Full Text] [Related]
14. Drug metabolism in normal children, lead-poisoned children, and normal adults.
Alvares AP; Kapelner S; Sassa S; Kappas A
Clin Pharmacol Ther; 1975 Feb; 17(2):179-83. PubMed ID: 804369
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves.
Semrad SD; McClure JT; Sams RA; Kaminski LM
Am J Vet Res; 1993 Nov; 54(11):1906-12. PubMed ID: 8291771
[TBL] [Abstract][Full Text] [Related]
16. Study on the neurotoxic effects of low-level lead exposure in rats.
Zhu ZW; Yang RL; Dong GJ; Zhao ZY
J Zhejiang Univ Sci B; 2005 Jul; 6(7):686-92. PubMed ID: 15973774
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics and tolerance of an orally administered combination preparation containing phenylbutazone and prednisolone in the dog].
Kietzmann M; Meyer-Lindenberg A; Engelke A; Nolte I
Dtsch Tierarztl Wochenschr; 1996 Jan; 103(1):14-6. PubMed ID: 8647008
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
19. Ethanol inhibition of reduced frequency-dependent rundown of calcium currents in acutely dissociated MS/nDB neurons from chronic in vivo lead-exposed adult rats.
Grover CA; Jasek MC; Frye GD; Griffith WH
Neurotoxicology; 1997; 18(1):179-90. PubMed ID: 9216000
[TBL] [Abstract][Full Text] [Related]
20. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women.
Visser M; Holinka CF; Coelingh Bennink HJ
Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
